Accessibility Tools

New data presented at ESMO 2020 have shown that immunotherapy is beneficial for patients with gastric and esophageal cancers who currently have poor survival.

Read More

Source: News-medical.net

  • The University of Texas Health Science Center at Houston
  • Baylor College of Medicine
  • Baylor University
  • Houston Methodist, Houston
  • American College of Gastroenterology